Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Positron-Emission Tomography | 78 | 2025 | 6550 | 4.440 |
Why?
|
Radiopharmaceuticals | 28 | 2025 | 2702 | 3.030 |
Why?
|
Fluorine Radioisotopes | 9 | 2025 | 405 | 1.400 |
Why?
|
tau Proteins | 13 | 2024 | 2106 | 1.320 |
Why?
|
Carbolines | 7 | 2024 | 288 | 1.220 |
Why?
|
Dopamine | 15 | 2024 | 1581 | 1.170 |
Why?
|
Receptors, Opioid, mu | 2 | 2025 | 167 | 1.080 |
Why?
|
Isoquinolines | 3 | 2024 | 349 | 0.920 |
Why?
|
Receptor, Muscarinic M4 | 1 | 2024 | 14 | 0.920 |
Why?
|
Brain | 39 | 2025 | 27163 | 0.870 |
Why?
|
Macaca mulatta | 9 | 2024 | 2345 | 0.790 |
Why?
|
Dopamine Plasma Membrane Transport Proteins | 3 | 2019 | 409 | 0.770 |
Why?
|
Neurotransmitter Agents | 4 | 2011 | 661 | 0.750 |
Why?
|
Fentanyl | 1 | 2025 | 451 | 0.750 |
Why?
|
Alzheimer Disease | 11 | 2024 | 8717 | 0.700 |
Why?
|
Receptors, Metabotropic Glutamate | 4 | 2022 | 188 | 0.700 |
Why?
|
Receptor, Cannabinoid, CB1 | 3 | 2015 | 137 | 0.640 |
Why?
|
Carbon Radioisotopes | 6 | 2024 | 544 | 0.640 |
Why?
|
Neostriatum | 1 | 2019 | 231 | 0.600 |
Why?
|
Raclopride | 10 | 2022 | 98 | 0.570 |
Why?
|
Zirconium | 2 | 2020 | 109 | 0.520 |
Why?
|
Tauopathies | 4 | 2024 | 325 | 0.510 |
Why?
|
Autopsy | 1 | 2019 | 1011 | 0.500 |
Why?
|
Tissue Distribution | 7 | 2025 | 2275 | 0.490 |
Why?
|
Molecular Imaging | 3 | 2022 | 822 | 0.490 |
Why?
|
Fluorodeoxyglucose F18 | 3 | 2021 | 2028 | 0.480 |
Why?
|
Synaptic Transmission | 1 | 2020 | 1175 | 0.450 |
Why?
|
Hot Temperature | 3 | 2018 | 1441 | 0.430 |
Why?
|
Image Processing, Computer-Assisted | 10 | 2023 | 8940 | 0.420 |
Why?
|
Basal Ganglia | 3 | 2013 | 549 | 0.410 |
Why?
|
Cell Division | 1 | 2020 | 4473 | 0.400 |
Why?
|
Tetrabenazine | 1 | 2012 | 21 | 0.390 |
Why?
|
Cell Cycle | 1 | 2020 | 2927 | 0.380 |
Why?
|
Radioactive Tracers | 2 | 2022 | 61 | 0.380 |
Why?
|
Depressive Disorder, Major | 4 | 2024 | 4813 | 0.380 |
Why?
|
Autoradiography | 5 | 2019 | 725 | 0.380 |
Why?
|
Ferrosoferric Oxide | 4 | 2021 | 348 | 0.370 |
Why?
|
Metal Nanoparticles | 1 | 2015 | 400 | 0.370 |
Why?
|
Radioisotopes | 4 | 2024 | 509 | 0.350 |
Why?
|
Demyelinating Diseases | 2 | 2022 | 354 | 0.340 |
Why?
|
Cerebral Angiography | 1 | 2015 | 1263 | 0.330 |
Why?
|
Magnetite Nanoparticles | 2 | 2020 | 310 | 0.310 |
Why?
|
Kinetics | 7 | 2024 | 6287 | 0.310 |
Why?
|
Models, Neurological | 3 | 2013 | 1747 | 0.300 |
Why?
|
Single-Cell Analysis | 1 | 2020 | 2538 | 0.300 |
Why?
|
Potassium Channels | 2 | 2021 | 534 | 0.300 |
Why?
|
Insulin-Secreting Cells | 2 | 2012 | 898 | 0.290 |
Why?
|
Myocardial Perfusion Imaging | 3 | 2020 | 669 | 0.290 |
Why?
|
Lutetium | 2 | 2024 | 38 | 0.280 |
Why?
|
Dopamine Antagonists | 6 | 2013 | 279 | 0.270 |
Why?
|
Central Nervous System Depressants | 3 | 2016 | 163 | 0.270 |
Why?
|
Computer Simulation | 7 | 2024 | 6260 | 0.270 |
Why?
|
Rats | 16 | 2025 | 23713 | 0.260 |
Why?
|
Animals | 46 | 2025 | 168965 | 0.260 |
Why?
|
Monocytes | 1 | 2015 | 2598 | 0.260 |
Why?
|
4-Aminopyridine | 2 | 2022 | 77 | 0.250 |
Why?
|
Ethanol | 5 | 2016 | 1330 | 0.250 |
Why?
|
Lactams, Macrocyclic | 2 | 2017 | 319 | 0.240 |
Why?
|
Microdialysis | 3 | 2011 | 156 | 0.240 |
Why?
|
Sex Characteristics | 1 | 2015 | 2647 | 0.230 |
Why?
|
Cyclic S-Oxides | 1 | 2024 | 23 | 0.230 |
Why?
|
Cell Proliferation | 1 | 2020 | 10455 | 0.230 |
Why?
|
Glutamate Carboxypeptidase II | 1 | 2024 | 90 | 0.230 |
Why?
|
Corpus Striatum | 5 | 2024 | 1217 | 0.230 |
Why?
|
Azabicyclo Compounds | 1 | 2024 | 66 | 0.220 |
Why?
|
Membrane Potential, Mitochondrial | 3 | 2021 | 293 | 0.220 |
Why?
|
Magnetic Resonance Imaging | 13 | 2024 | 36582 | 0.210 |
Why?
|
Kv1.2 Potassium Channel | 1 | 2022 | 14 | 0.210 |
Why?
|
Kv1.1 Potassium Channel | 1 | 2022 | 29 | 0.210 |
Why?
|
Receptors, Opioid, kappa | 1 | 2024 | 134 | 0.210 |
Why?
|
Allosteric Regulation | 1 | 2024 | 424 | 0.200 |
Why?
|
Neurodegenerative Diseases | 2 | 2024 | 1089 | 0.200 |
Why?
|
Succinimides | 1 | 2021 | 83 | 0.190 |
Why?
|
Pyrans | 1 | 2022 | 47 | 0.190 |
Why?
|
Picolinic Acids | 1 | 2022 | 48 | 0.190 |
Why?
|
Sulfonic Acids | 1 | 2021 | 103 | 0.190 |
Why?
|
Aminopyridines | 3 | 2020 | 578 | 0.190 |
Why?
|
Isotope Labeling | 2 | 2020 | 390 | 0.180 |
Why?
|
Quaternary Ammonium Compounds | 1 | 2021 | 204 | 0.180 |
Why?
|
Cromolyn Sodium | 1 | 2021 | 76 | 0.180 |
Why?
|
Placebo Effect | 1 | 2024 | 516 | 0.170 |
Why?
|
Humans | 61 | 2025 | 767040 | 0.170 |
Why?
|
Fragile X Syndrome | 1 | 2021 | 116 | 0.170 |
Why?
|
Organophosphorus Compounds | 1 | 2021 | 209 | 0.170 |
Why?
|
Male | 43 | 2025 | 364203 | 0.170 |
Why?
|
Diabetes Mellitus, Experimental | 3 | 2017 | 1121 | 0.160 |
Why?
|
Carbon Isotopes | 3 | 2015 | 453 | 0.160 |
Why?
|
Reproducibility of Results | 9 | 2024 | 20169 | 0.160 |
Why?
|
Tissue Banks | 1 | 2019 | 183 | 0.150 |
Why?
|
Dopamine Agents | 1 | 2019 | 186 | 0.150 |
Why?
|
Cerebrovascular Circulation | 3 | 2023 | 2672 | 0.150 |
Why?
|
Nanoparticles | 3 | 2020 | 1966 | 0.150 |
Why?
|
Blood-Brain Barrier | 2 | 2022 | 1029 | 0.150 |
Why?
|
Receptors, Dopamine D3 | 2 | 2022 | 106 | 0.150 |
Why?
|
Phantoms, Imaging | 5 | 2023 | 2487 | 0.150 |
Why?
|
Ligands | 4 | 2022 | 3273 | 0.150 |
Why?
|
Myocardium | 3 | 2021 | 4765 | 0.150 |
Why?
|
Coronary Circulation | 3 | 2020 | 1603 | 0.140 |
Why?
|
Football | 1 | 2023 | 504 | 0.140 |
Why?
|
Algorithms | 7 | 2024 | 14098 | 0.140 |
Why?
|
Aniline Compounds | 1 | 2023 | 1080 | 0.140 |
Why?
|
Diabetes Mellitus, Type 1 | 1 | 2012 | 3449 | 0.140 |
Why?
|
Coronary Vessels | 2 | 2020 | 3114 | 0.140 |
Why?
|
Radiometry | 1 | 2022 | 818 | 0.140 |
Why?
|
Apolipoprotein E4 | 1 | 2021 | 709 | 0.140 |
Why?
|
Individuality | 1 | 2018 | 303 | 0.140 |
Why?
|
Neuralgia | 1 | 2023 | 619 | 0.140 |
Why?
|
Phosphatidylcholines | 1 | 2018 | 405 | 0.140 |
Why?
|
Click Chemistry | 1 | 2017 | 100 | 0.130 |
Why?
|
Contrast Media | 4 | 2024 | 5329 | 0.130 |
Why?
|
Models, Biological | 3 | 2016 | 9464 | 0.130 |
Why?
|
Lymphangioleiomyomatosis | 1 | 2018 | 206 | 0.130 |
Why?
|
Metabolic Clearance Rate | 1 | 2016 | 361 | 0.130 |
Why?
|
Cocaine | 2 | 2019 | 944 | 0.130 |
Why?
|
Mitochondria | 2 | 2020 | 3678 | 0.130 |
Why?
|
Oxygen Radioisotopes | 1 | 2015 | 59 | 0.120 |
Why?
|
Pyridazines | 1 | 2017 | 199 | 0.120 |
Why?
|
Doxorubicin | 1 | 2022 | 2229 | 0.120 |
Why?
|
Carotid Artery Diseases | 1 | 2021 | 872 | 0.120 |
Why?
|
Rest | 2 | 2017 | 941 | 0.120 |
Why?
|
Microglia | 2 | 2022 | 1370 | 0.120 |
Why?
|
Oxazoles | 1 | 2016 | 198 | 0.120 |
Why?
|
Nanostructures | 2 | 2017 | 549 | 0.120 |
Why?
|
Neurofibrillary Tangles | 1 | 2017 | 457 | 0.120 |
Why?
|
Deferoxamine | 1 | 2015 | 155 | 0.120 |
Why?
|
Rats, Sprague-Dawley | 7 | 2022 | 8108 | 0.120 |
Why?
|
Amyloid beta-Peptides | 6 | 2023 | 3886 | 0.120 |
Why?
|
Receptors, Dopamine D2 | 2 | 2016 | 471 | 0.120 |
Why?
|
Iron Chelating Agents | 1 | 2015 | 141 | 0.110 |
Why?
|
HeLa Cells | 1 | 2020 | 3073 | 0.110 |
Why?
|
Adult | 22 | 2024 | 223317 | 0.110 |
Why?
|
Swine | 6 | 2020 | 5987 | 0.110 |
Why?
|
Alcoholism | 2 | 2016 | 1980 | 0.110 |
Why?
|
Female | 26 | 2024 | 396660 | 0.100 |
Why?
|
Mice | 10 | 2025 | 81912 | 0.100 |
Why?
|
Wireless Technology | 1 | 2014 | 99 | 0.100 |
Why?
|
Head Movements | 1 | 2014 | 149 | 0.100 |
Why?
|
Tomography, Emission-Computed, Single-Photon | 1 | 2018 | 1142 | 0.100 |
Why?
|
Imaging, Three-Dimensional | 2 | 2024 | 4052 | 0.100 |
Why?
|
Flumazenil | 1 | 2012 | 84 | 0.100 |
Why?
|
Pyridines | 1 | 2024 | 2890 | 0.100 |
Why?
|
Brain Concussion | 1 | 2023 | 1431 | 0.100 |
Why?
|
Reward | 1 | 2018 | 980 | 0.100 |
Why?
|
Organ Specificity | 1 | 2016 | 1966 | 0.100 |
Why?
|
Neuroglia | 1 | 2017 | 960 | 0.090 |
Why?
|
Alcoholic Intoxication | 2 | 2016 | 171 | 0.090 |
Why?
|
Tumor Microenvironment | 1 | 2024 | 3944 | 0.090 |
Why?
|
Middle Aged | 16 | 2024 | 223233 | 0.090 |
Why?
|
Alcohol Drinking | 3 | 2016 | 4045 | 0.090 |
Why?
|
Protein-Tyrosine Kinases | 2 | 2017 | 2428 | 0.090 |
Why?
|
Triazoles | 1 | 2016 | 903 | 0.090 |
Why?
|
Sensitivity and Specificity | 3 | 2024 | 14672 | 0.090 |
Why?
|
Dopamine Agonists | 1 | 2013 | 346 | 0.090 |
Why?
|
Tuberous Sclerosis | 1 | 2018 | 1039 | 0.090 |
Why?
|
Locus Coeruleus | 2 | 2023 | 241 | 0.090 |
Why?
|
Aged | 13 | 2023 | 171319 | 0.090 |
Why?
|
Protein Kinase Inhibitors | 2 | 2017 | 5693 | 0.090 |
Why?
|
Plaque, Atherosclerotic | 1 | 2021 | 1549 | 0.090 |
Why?
|
Movement | 1 | 2016 | 1473 | 0.080 |
Why?
|
Stress, Physiological | 1 | 2017 | 1407 | 0.080 |
Why?
|
Extracellular Space | 1 | 2011 | 563 | 0.080 |
Why?
|
Motion | 2 | 2023 | 784 | 0.080 |
Why?
|
Chromatography, Gel | 2 | 2020 | 634 | 0.080 |
Why?
|
Receptor Protein-Tyrosine Kinases | 1 | 2017 | 1621 | 0.080 |
Why?
|
Macaca fascicularis | 2 | 2022 | 908 | 0.080 |
Why?
|
Skin Diseases | 1 | 2017 | 1083 | 0.080 |
Why?
|
Brain Injuries | 1 | 2020 | 2053 | 0.080 |
Why?
|
Stress, Psychological | 1 | 2024 | 4526 | 0.080 |
Why?
|
Linear Models | 2 | 2024 | 5875 | 0.080 |
Why?
|
Receptors, Dopamine | 2 | 2006 | 291 | 0.070 |
Why?
|
Prefrontal Cortex | 1 | 2018 | 2224 | 0.070 |
Why?
|
Alcohols | 1 | 2008 | 94 | 0.070 |
Why?
|
Proto-Oncogene Proteins | 2 | 2017 | 4522 | 0.070 |
Why?
|
Models, Theoretical | 1 | 2019 | 3561 | 0.070 |
Why?
|
Permeability | 2 | 2022 | 721 | 0.070 |
Why?
|
Recurrence | 1 | 2019 | 8504 | 0.070 |
Why?
|
Wound Healing | 1 | 2017 | 2800 | 0.070 |
Why?
|
Lactams | 2 | 2017 | 159 | 0.070 |
Why?
|
Pyrimidines | 2 | 2017 | 3044 | 0.070 |
Why?
|
Models, Statistical | 3 | 2011 | 5098 | 0.070 |
Why?
|
Reference Standards | 3 | 2017 | 1011 | 0.060 |
Why?
|
Methamphetamine | 1 | 2008 | 167 | 0.060 |
Why?
|
Young Adult | 8 | 2024 | 59980 | 0.060 |
Why?
|
Aged, 80 and over | 6 | 2023 | 59548 | 0.060 |
Why?
|
Actinium | 1 | 2024 | 2 | 0.060 |
Why?
|
Cerebral Arteries | 1 | 2007 | 490 | 0.060 |
Why?
|
Receptors, Bombesin | 1 | 2024 | 27 | 0.060 |
Why?
|
Peptide Fragments | 2 | 2021 | 5141 | 0.060 |
Why?
|
Reference Values | 1 | 2012 | 4918 | 0.060 |
Why?
|
B-Lymphocytes | 1 | 2017 | 4787 | 0.060 |
Why?
|
Islets of Langerhans | 1 | 2010 | 1350 | 0.060 |
Why?
|
Brain Chemistry | 1 | 2007 | 951 | 0.060 |
Why?
|
Skin | 1 | 2017 | 4499 | 0.060 |
Why?
|
Brain Mapping | 3 | 2018 | 6597 | 0.050 |
Why?
|
Monoamine Oxidase | 1 | 2024 | 179 | 0.050 |
Why?
|
Cues | 1 | 2008 | 877 | 0.050 |
Why?
|
Parkinson Disease | 1 | 2017 | 2886 | 0.050 |
Why?
|
Head | 1 | 2008 | 926 | 0.050 |
Why?
|
Image Interpretation, Computer-Assisted | 2 | 2024 | 3370 | 0.050 |
Why?
|
Photic Stimulation | 1 | 2008 | 1989 | 0.050 |
Why?
|
Cross-Sectional Studies | 2 | 2022 | 26325 | 0.050 |
Why?
|
Prostatic Neoplasms | 1 | 2024 | 11097 | 0.050 |
Why?
|
Brain Ischemia | 1 | 2015 | 3001 | 0.050 |
Why?
|
Melanins | 1 | 2024 | 291 | 0.050 |
Why?
|
Disease Models, Animal | 4 | 2022 | 18330 | 0.050 |
Why?
|
Radiochemistry | 1 | 2021 | 47 | 0.050 |
Why?
|
Pyrazoles | 3 | 2017 | 2028 | 0.050 |
Why?
|
Endopeptidases | 1 | 2024 | 762 | 0.050 |
Why?
|
Fragile X Mental Retardation Protein | 1 | 2021 | 115 | 0.040 |
Why?
|
Signal Processing, Computer-Assisted | 1 | 2008 | 1458 | 0.040 |
Why?
|
Mitochondria, Heart | 1 | 2022 | 229 | 0.040 |
Why?
|
Cricetulus | 1 | 2022 | 810 | 0.040 |
Why?
|
Neural Pathways | 2 | 2024 | 3078 | 0.040 |
Why?
|
Haplorhini | 1 | 2021 | 520 | 0.040 |
Why?
|
Chromatography, Thin Layer | 1 | 2020 | 211 | 0.040 |
Why?
|
Antigens, Surface | 1 | 2024 | 1617 | 0.040 |
Why?
|
Primates | 1 | 2022 | 519 | 0.040 |
Why?
|
Feasibility Studies | 3 | 2020 | 5311 | 0.040 |
Why?
|
Entorhinal Cortex | 1 | 2022 | 285 | 0.040 |
Why?
|
Nitrogen Isotopes | 1 | 2020 | 80 | 0.040 |
Why?
|
Gene Knock-In Techniques | 1 | 2021 | 419 | 0.040 |
Why?
|
Muscle, Skeletal | 1 | 2015 | 4968 | 0.040 |
Why?
|
Cerebral Cortex | 3 | 2024 | 5754 | 0.040 |
Why?
|
Copper Radioisotopes | 1 | 2020 | 99 | 0.040 |
Why?
|
Tomography, X-Ray Computed | 2 | 2020 | 20741 | 0.040 |
Why?
|
Rats, Wistar | 2 | 2015 | 1885 | 0.040 |
Why?
|
Ammonia | 1 | 2020 | 244 | 0.040 |
Why?
|
Fluoroacetates | 1 | 2018 | 13 | 0.040 |
Why?
|
Cricetinae | 1 | 2022 | 2415 | 0.040 |
Why?
|
Atrophy | 1 | 2023 | 1631 | 0.040 |
Why?
|
Iron Radioisotopes | 1 | 2018 | 19 | 0.040 |
Why?
|
Chelating Agents | 1 | 2020 | 384 | 0.040 |
Why?
|
Antibiotics, Antineoplastic | 1 | 2022 | 678 | 0.040 |
Why?
|
Toll-Like Receptor 4 | 1 | 2021 | 588 | 0.040 |
Why?
|
Respiration | 1 | 2024 | 1655 | 0.040 |
Why?
|
Diagnostic Imaging | 1 | 2012 | 3530 | 0.040 |
Why?
|
Conditioning, Operant | 1 | 2018 | 306 | 0.030 |
Why?
|
Membrane Potentials | 1 | 2020 | 1085 | 0.030 |
Why?
|
Flow Cytometry | 2 | 2018 | 5891 | 0.030 |
Why?
|
Microspheres | 1 | 2020 | 774 | 0.030 |
Why?
|
Adolescent | 3 | 2015 | 89046 | 0.030 |
Why?
|
Radioligand Assay | 1 | 2017 | 365 | 0.030 |
Why?
|
Supranuclear Palsy, Progressive | 1 | 2017 | 82 | 0.030 |
Why?
|
Smoking | 1 | 2013 | 9081 | 0.030 |
Why?
|
Tritium | 1 | 2017 | 707 | 0.030 |
Why?
|
Choline | 1 | 2018 | 511 | 0.030 |
Why?
|
Regional Blood Flow | 1 | 2020 | 1479 | 0.030 |
Why?
|
Memory Disorders | 1 | 2023 | 1193 | 0.030 |
Why?
|
Cross-Over Studies | 1 | 2022 | 2105 | 0.030 |
Why?
|
Phosphorylation | 2 | 2017 | 8310 | 0.030 |
Why?
|
TDP-43 Proteinopathies | 1 | 2015 | 40 | 0.030 |
Why?
|
Fluorescence | 1 | 2018 | 751 | 0.030 |
Why?
|
Electric Power Supplies | 1 | 2015 | 94 | 0.030 |
Why?
|
Inflammation | 1 | 2015 | 10869 | 0.030 |
Why?
|
Stress Disorders, Post-Traumatic | 1 | 2013 | 4629 | 0.030 |
Why?
|
Phagocytosis | 1 | 2021 | 1526 | 0.030 |
Why?
|
Biochemical Phenomena | 1 | 2015 | 58 | 0.030 |
Why?
|
Time Factors | 3 | 2012 | 40154 | 0.030 |
Why?
|
Adenosine | 1 | 2020 | 812 | 0.030 |
Why?
|
Frontotemporal Lobar Degeneration | 1 | 2015 | 102 | 0.030 |
Why?
|
Carbocyanines | 1 | 2015 | 177 | 0.030 |
Why?
|
Breath Tests | 1 | 2016 | 297 | 0.030 |
Why?
|
Perfusion Imaging | 1 | 2016 | 193 | 0.030 |
Why?
|
Glycogen Synthase Kinase 3 | 1 | 2016 | 414 | 0.030 |
Why?
|
Inclusion Bodies | 1 | 2015 | 277 | 0.030 |
Why?
|
Immunohistochemistry | 2 | 2018 | 11063 | 0.030 |
Why?
|
Neuroprotective Agents | 1 | 2021 | 956 | 0.030 |
Why?
|
Scattering, Radiation | 1 | 2015 | 486 | 0.030 |
Why?
|
Temporal Lobe | 1 | 2022 | 1717 | 0.030 |
Why?
|
Image Enhancement | 1 | 2024 | 2867 | 0.030 |
Why?
|
Bipolar Disorder | 1 | 2011 | 5130 | 0.030 |
Why?
|
Thigh | 1 | 2015 | 236 | 0.030 |
Why?
|
Palmitic Acids | 1 | 2013 | 53 | 0.030 |
Why?
|
Analysis of Variance | 2 | 2013 | 6215 | 0.030 |
Why?
|
Polyunsaturated Alkamides | 1 | 2013 | 29 | 0.030 |
Why?
|
Glycerides | 1 | 2013 | 67 | 0.030 |
Why?
|
Myocytes, Cardiac | 1 | 2022 | 1672 | 0.030 |
Why?
|
Plaque, Amyloid | 1 | 2017 | 769 | 0.030 |
Why?
|
Papio | 1 | 2014 | 672 | 0.030 |
Why?
|
Ethanolamines | 1 | 2013 | 152 | 0.030 |
Why?
|
Receptors, GABA | 1 | 2014 | 312 | 0.030 |
Why?
|
Arachidonic Acids | 1 | 2013 | 296 | 0.030 |
Why?
|
Endocannabinoids | 1 | 2013 | 113 | 0.020 |
Why?
|
Markov Chains | 1 | 2016 | 976 | 0.020 |
Why?
|
Molecular Structure | 1 | 2016 | 1882 | 0.020 |
Why?
|
Oxygen Consumption | 1 | 2018 | 1873 | 0.020 |
Why?
|
Nerve Net | 1 | 2024 | 2307 | 0.020 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2016 | 10748 | 0.020 |
Why?
|
Crystallography, X-Ray | 1 | 2016 | 1947 | 0.020 |
Why?
|
Microscopy, Confocal | 1 | 2017 | 1969 | 0.020 |
Why?
|
Heart | 1 | 2024 | 4429 | 0.020 |
Why?
|
Putamen | 1 | 2012 | 288 | 0.020 |
Why?
|
Cadaver | 1 | 2015 | 1362 | 0.020 |
Why?
|
Safety | 1 | 2015 | 1157 | 0.020 |
Why?
|
Uncertainty | 1 | 2016 | 765 | 0.020 |
Why?
|
Mice, Inbred C57BL | 2 | 2021 | 22361 | 0.020 |
Why?
|
Protein Binding | 2 | 2014 | 9327 | 0.020 |
Why?
|
Rats, Zucker | 1 | 2010 | 130 | 0.020 |
Why?
|
Amides | 1 | 2013 | 451 | 0.020 |
Why?
|
Case-Control Studies | 2 | 2022 | 22254 | 0.020 |
Why?
|
Streptozocin | 1 | 2010 | 189 | 0.020 |
Why?
|
Amyloid | 1 | 2015 | 849 | 0.020 |
Why?
|
Double-Blind Method | 1 | 2024 | 12451 | 0.020 |
Why?
|
Chromatography, High Pressure Liquid | 1 | 2014 | 1531 | 0.020 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2017 | 3804 | 0.020 |
Why?
|
Lipid Metabolism | 1 | 2018 | 1895 | 0.020 |
Why?
|
Intracranial Hemorrhages | 1 | 2015 | 810 | 0.020 |
Why?
|
Magnetic Resonance Spectroscopy | 1 | 2020 | 3684 | 0.020 |
Why?
|
Fluorescent Dyes | 1 | 2018 | 1928 | 0.020 |
Why?
|
Blotting, Western | 1 | 2017 | 5022 | 0.020 |
Why?
|
Dopamine Uptake Inhibitors | 1 | 2011 | 286 | 0.020 |
Why?
|
Monte Carlo Method | 1 | 2015 | 1250 | 0.020 |
Why?
|
Polyethylene Glycols | 1 | 2015 | 1188 | 0.020 |
Why?
|
Radionuclide Imaging | 1 | 2013 | 1987 | 0.020 |
Why?
|
Xenograft Model Antitumor Assays | 1 | 2017 | 3608 | 0.020 |
Why?
|
Glucagon-Like Peptide 1 | 1 | 2011 | 374 | 0.020 |
Why?
|
Mice, Nude | 1 | 2015 | 3618 | 0.020 |
Why?
|
Rabbits | 1 | 2015 | 4751 | 0.020 |
Why?
|
Microfluidics | 1 | 2014 | 650 | 0.020 |
Why?
|
Gene Expression | 1 | 2021 | 7587 | 0.020 |
Why?
|
Gene Expression Profiling | 1 | 2024 | 9532 | 0.020 |
Why?
|
Bayes Theorem | 1 | 2016 | 2353 | 0.020 |
Why?
|
Statistics, Nonparametric | 1 | 2013 | 2850 | 0.020 |
Why?
|
Membrane Proteins | 1 | 2024 | 7868 | 0.020 |
Why?
|
Cell Survival | 1 | 2017 | 5750 | 0.020 |
Why?
|
Imidazoles | 1 | 2013 | 1169 | 0.020 |
Why?
|
Infusion Pumps | 1 | 2008 | 162 | 0.020 |
Why?
|
Lipopolysaccharides | 1 | 2014 | 2217 | 0.020 |
Why?
|
Acute Disease | 1 | 2017 | 7236 | 0.020 |
Why?
|
Fingers | 1 | 2010 | 508 | 0.020 |
Why?
|
Cell Line | 1 | 2021 | 15567 | 0.020 |
Why?
|
Macrophages | 1 | 2021 | 5785 | 0.020 |
Why?
|
DNA-Binding Proteins | 1 | 2024 | 9612 | 0.020 |
Why?
|
Insulin | 2 | 2011 | 6602 | 0.020 |
Why?
|
Whole Body Imaging | 1 | 2008 | 283 | 0.020 |
Why?
|
Models, Molecular | 1 | 2016 | 5388 | 0.020 |
Why?
|
Neoplasms | 1 | 2015 | 22350 | 0.020 |
Why?
|
Stereotaxic Techniques | 1 | 2008 | 551 | 0.020 |
Why?
|
Gyrus Cinguli | 1 | 2012 | 1118 | 0.020 |
Why?
|
Mice, Transgenic | 1 | 2018 | 9551 | 0.020 |
Why?
|
Biopsy | 1 | 2017 | 6777 | 0.020 |
Why?
|
Frontal Lobe | 1 | 2012 | 1408 | 0.020 |
Why?
|
Cells, Cultured | 1 | 2021 | 18989 | 0.020 |
Why?
|
Heart Ventricles | 1 | 2017 | 3837 | 0.020 |
Why?
|
Hydrocortisone | 1 | 2013 | 1840 | 0.020 |
Why?
|
Artifacts | 1 | 2014 | 1904 | 0.020 |
Why?
|
Video Recording | 1 | 2010 | 977 | 0.010 |
Why?
|
Piperidines | 1 | 2013 | 1667 | 0.010 |
Why?
|
Amygdala | 1 | 2012 | 1375 | 0.010 |
Why?
|
Gene Expression Regulation | 1 | 2021 | 11923 | 0.010 |
Why?
|
Cluster Analysis | 1 | 2010 | 2721 | 0.010 |
Why?
|
Chronic Disease | 1 | 2017 | 9362 | 0.010 |
Why?
|
Depression | 1 | 2022 | 8234 | 0.010 |
Why?
|
Infusions, Intravenous | 1 | 2007 | 2227 | 0.010 |
Why?
|
Psychiatric Status Rating Scales | 1 | 2011 | 6023 | 0.010 |
Why?
|
Dementia | 1 | 2015 | 2741 | 0.010 |
Why?
|
Electrocardiography | 1 | 2014 | 6409 | 0.010 |
Why?
|
Motor Activity | 1 | 2010 | 2713 | 0.010 |
Why?
|
Hippocampus | 1 | 2012 | 3777 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2017 | 15925 | 0.010 |
Why?
|
Prospective Studies | 1 | 2023 | 54886 | 0.010 |
Why?
|
Cell Line, Tumor | 1 | 2015 | 17097 | 0.010 |
Why?
|
Logistic Models | 1 | 2013 | 13284 | 0.010 |
Why?
|
Cerebellum | 1 | 2005 | 1521 | 0.010 |
Why?
|
Kidney | 1 | 2011 | 7063 | 0.010 |
Why?
|
Liver | 1 | 2011 | 7578 | 0.010 |
Why?
|
Cohort Studies | 1 | 2017 | 41718 | 0.010 |
Why?
|
Radiography | 1 | 2005 | 6975 | 0.010 |
Why?
|
Research Design | 1 | 2008 | 6210 | 0.010 |
Why?
|
Mutation | 1 | 2017 | 30211 | 0.010 |
Why?
|
Predictive Value of Tests | 1 | 2008 | 15424 | 0.010 |
Why?
|